DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells | |
Jing, W; Song, N; Liu, YP; Qu, XJ; Hou, KZ; Yang, XH; Che, XF | |
刊名 | MOLECULAR MEDICINE REPORTS |
2018 | |
卷号 | Vol.17 No.1页码:117-124 |
关键词 | cell cycle checkpoint kinase 1 DNA methyltransferase 3a pancreatic ductal adenocarcinoma chemosensitivity |
ISSN号 | 1791-2997 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5465512 |
专题 | 湖南大学 |
作者单位 | 1.China Med Univ, Dept Oncol, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China 2.China Med Univ, Dept Pathol, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China 3.China Med Univ, Dept Med Oncol, Hosp 1, 155 North Nanjing St, Shenyang 110001, Liaoning, Peoples R China |
推荐引用方式 GB/T 7714 | Jing, W,Song, N,Liu, YP,et al. DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells[J]. MOLECULAR MEDICINE REPORTS,2018,Vol.17 No.1:117-124. |
APA | Jing, W.,Song, N.,Liu, YP.,Qu, XJ.,Hou, KZ.,...&Che, XF.(2018).DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells.MOLECULAR MEDICINE REPORTS,Vol.17 No.1,117-124. |
MLA | Jing, W,et al."DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells".MOLECULAR MEDICINE REPORTS Vol.17 No.1(2018):117-124. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论